Ebal, Martiniano M.
HRN: 14-63-76 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/22/2023
CEFUROXIME 1.5GM (VIAL)
01/22/2023
01/28/2023
IV
1.5g
Q8H
Community Acquired Pneumonia - Moderate Risk
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes